Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.

Barbet J, Arlicot N, Gaugler MH, Chérel M, Guilloteau D, Kraeber-Bodéré F.

DOI: 10.3389/fmed.2016.00074
Published: 2017-01-11
Container: Front Med (Lausanne)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2016.00074,
  title = {Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.},
  author = {Barbet J and  Arlicot N and  Gaugler MH and  Chérel M and  Guilloteau D and  Kraeber-Bodéré F.},
  year = {2016},
  journal = {Front Med (Lausanne)},
  doi = {10.3389/fmed.2016.00074},
  url = {https://doi.org/10.3389/fmed.2016.00074}
}

RIS

TY  - JOUR
TI  - Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.
AU  - Barbet J
AU  -  Arlicot N
AU  -  Gaugler MH
AU  -  Chérel M
AU  -  Guilloteau D
AU  -  Kraeber-Bodéré F.
PY  - 2016
JO  - Front Med (Lausanne)
DO  - 10.3389/fmed.2016.00074
UR  - https://doi.org/10.3389/fmed.2016.00074
ER  -

APA

J, B., N, A., MH, G., M, C., D, G., & F., K. (2016). Editorial: Innovative Radiopharmaceuticals in Oncology and Neurology.. Front Med (Lausanne). https://doi.org/10.3389/fmed.2016.00074

Source records

europe-pmc · retrieved 2026-09-24T20:09:10.315Z
hal · retrieved 2026-09-24T20:09:10.358Z